24-Hour ambulatory blood pressure monitoring in patients with malignancies enrolled in phase I oncological studies
- Conditions
- cancer / hypertensie10027655
- Registration Number
- NL-OMON32306
- Lead Sponsor
- Slotervaartziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
- enrolled in ongoing or future phase I studies of novel anti-cancer agents at the NKI-AVL
- scheduled to be hospitalized for at least a 24 hours during the phase I trial
Exclusion Criteria
- currently associated with essential hypertension, cardiovascular disease or renal impairment
- currently treated with drugs that are known to have an effect on the cardiovascular and/or the renovascular system
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Mathematical models will be fitted to the 24-hour blood pressure data.</p><br>
- Secondary Outcome Measures
Name Time Method <p>not applicable</p><br>